Pulmonx Corporation Common Stock Share Price
NASDAQ: LUNGHealthcare
Live Pulmonx Corporation Common Stock Share Price Chart
O H L
Pulmonx Corporation Common Stock Performance Overview
Days Range
▼
$2.00Low
$2.02High
Markets Today
| Previous Close | $1.98 |
|---|---|
| Open | $2.00 |
| Volume | 57,695 |
| Day's Range | $2.00 - $2.02 |
| 52W Range | $1.13 - $2.89 |
| Market Cap | $83.75 M |
Historical Performance
| 1M Returns | -12.39 |
|---|---|
| 3M Returns | +54.69 |
| 6M Returns | +33.78 |
| 1Y Returns | +23.75 |
| 5Y Returns | -94.87 |
| 10Y Returns | NA |
Pulmonx Corporation Common Stock Fundamentals
| Market Cap | $83.75 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $90.50 M |
| ROE TTM | -0.77 |
| EPS TTM | $-1.16 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.14 |
| EBITDA | $-52.61 M |
| Profit Margin | -59.67 |
| Market Cap | $83.75 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $90.50 M |
| ROE TTM | -0.77 |
| EPS TTM | $-1.16 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.14 |
| EBITDA | $-52.61 M |
| Profit Margin | -59.67 |
Pulmonx Corporation Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $22.54 M | $23.86 M | $21.50 M | $22.60 M | $20.59 M | $22.76 M |
| Gross Profit + | $16.34 M | $17.20 M | $16.05 M | $17.54 M | $16.04 M | $17.74 M |
| Operating Income | -$14.56 M | -$14.80 M | -$14.39 M | -$9.90 M | -$12.96 M | -$9.06 M |
| EBITDA | -$14.29 M | -$14.51 M | -$14.15 M | -$9.67 M | -$12.74 M | -$8.84 M |
| Interest Expense | -$781.00 K | -$799.00 K | -$805.00 K | -$770.00 K | -$976.00 K | -$1.22 M |
| Depreciation | $278.00 K | $299.00 K | $246.00 K | $231.00 K | $220.00 K | $222.00 K |
| Income Before Tax | -$14.31 M | -$15.00 M | -$13.83 M | -$10.24 M | -$13.51 M | -$9.95 M |
| Income Tax Expense | $135.00 K | $177.00 K | $128.00 K | $186.00 K | $149.00 K | $133.00 K |
| Net Income + | -$14.45 M | -$15.17 M | -$13.96 M | -$10.43 M | -$13.65 M | -$10.08 M |
| Net Profit Margin | -64.11% | -63.59% | -64.91% | -46.13% | -66.33% | -44.3% |
Pulmonx Corporation Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $40.00 K | $41.00 K | $41.00 K | $42.00 K | $42.00 K | $43.00 K |
| Reserve & Surplus | -$479.80 M | -$494.54 M | -$508.89 M | -$519.20 M | -$533.04 M | -$543.24 M |
| Non-Current Liabilities | $48.12 M | $55.65 M | $55.37 M | $55.12 M | $55.30 M | $55.13 M |
| Current Liabilities | $24.95 M | $22.45 M | $22.88 M | $20.06 M | $18.91 M | $20.41 M |
| Total Liabilities | $73.07 M | $78.10 M | $78.25 M | $75.17 M | $74.20 M | $75.54 M |
| Fixed Assets | $2.83 M | $2.66 M | $2.44 M | $2.22 M | $2.06 M | $1.89 M |
| Current Assets | $123.94 M | $120.02 M | $111.23 M | $101.68 M | $92.75 M | $88.13 M |
| Total Assets | $150.74 M | $147.19 M | $138.28 M | $129.29 M | $119.97 M | $114.73 M |
Pulmonx Corporation Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$14.45 M | -$15.17 M | -$13.96 M | -$10.43 M | -$13.65 M | -$10.08 M |
| Operating Cash Flow | -$13.22 M | -$3.91 M | -$8.16 M | -$7.08 M | -$10.10 M | -$5.21 M |
| Investing Cash Flow | $16.31 M | $5.47 M | $8.71 M | -$13.00 K | -$9.00 K | -$1.00 K |
| Financing Cash Flow | $664.00 K | -$67.00 K | $181.00 K | $55.00 K | $2.03 M | -$513.00 K |
| Change in Cash | $3.65 M | $913.00 K | $1.08 M | -$6.80 M | -$8.18 M | -$5.73 M |
Pulmonx Corporation Common Stock Return Calculator
The Pulmonx Corporation Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$513
Invested Amount$10,000
Est. Returns$-9,487
About Pulmonx Corporation Common Stock
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Popular Stocks
FAQs
What is the share price of Pulmonx Corporation Common Stock today?
Pulmonx Corporation Common Stock (LUNG) share price as of September 18, 2026 is $1.98. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Pulmonx Corporation Common Stock?
Yes, Indian Investors can invest in the Pulmonx Corporation Common Stock (LUNG) Share by opening an international trading account with Angel One.
How can I purchase Pulmonx Corporation Common Stock shares in India?
Purchasing Pulmonx Corporation Common Stock (LUNG) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Pulmonx Corporation Common Stock (LUNG) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Pulmonx Corporation Common Stock?
Yes, you can purchase fractional shares of Pulmonx Corporation Common Stock (LUNG) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Pulmonx Corporation Common Stock?
The market capitalization of Pulmonx Corporation Common Stock on September 18, 2026, is $83.75 M.
In which sector Pulmonx Corporation Common Stock belongs?
Pulmonx Corporation Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Pulmonx Corporation Common Stock stocks?
In order to invest in Pulmonx Corporation Common Stock (LUNG) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
